BlackRock
MENS

BlackRock’s Jyong Biotech MENS Stock Holding History

BlackRock’s Portfolio MENS Stock Details MENS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$539K Buy
260,317
+1,557
+0.6% +$3.3K ﹤0.01% 4557
2026
Q1 		$556K Sell
258,760
-2,063
-0.8% -$5.05K ﹤0.01% 4501
2025
Q4 		$1.03M Buy
+260,823
New +$9.21M ﹤0.01% 4297

Other funds holding MENS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock's MENS Position: Q2 2026 in Review

BlackRock increased its Jyong Biotech (MENS) stake by 0.6% in Q2 2026, buying an estimated $3.3K and bringing the position to 260,317 shares worth $539K. The position accounts for ﹤0.01% of the portfolio, ranked #4557.

BlackRock first reported a position in MENS in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.03M in Q4 2025. 19 funds tracked by Wall St. Rank hold MENS as of Q2 2026.

  • BlackRock held 260,317 shares of Jyong Biotech worth $539K as of Q2 2026.
  • BlackRock bought 1,557 Jyong Biotech shares in Q2 2026, an estimated $3.3K.
  • Jyong Biotech made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4557 holding.
  • BlackRock first reported a position in Jyong Biotech in Q4 2025 and has held it in 3 quarters since.
  • BlackRock's Jyong Biotech position peaked at $1.03M in Q4 2025.
  • 19 funds tracked by Wall St. Rank held Jyong Biotech as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.